Continue
By using our website you accept our cookies policy.Find out more

Biomedical Catalyst 2019 Round 1: Feasibility & Primer Awards

Registration is closed
Funding details
Registration opens
21 Jan 2019, 00:00
Registration closes
03 Apr 2019, 12:00
Closes
03 Apr 2019, 12:00
Award
A share of up to £3 million
Organisation
Innovate UK & Medical Research Council
Summary

The Biomedical Catalyst (BMC) funding programme supports UK businesses to test and develop innovative technologies for health and care. It supports ideas for: disease prevention and management; disease detection and diagnosis; and tailored treatments that change a disease or offer potential cures.

The programme, run by Innovate UK and the Medical Research Council, provides funding to help UK SMEs speed up the process of bringing new products to market and secure onward investment.

Support is available for any life science sector or discipline, including medical technologies and devices, advanced therapies (cell and gene therapies), digital health, drug discovery, and diagnostics. The Biomedical Catalyst has 4 competitions designed to support SMEs to progress projects that are at different stages of development:

1.     Feasibility Award

2.     Primer Award

3.     Early-stage Award

4.     Late-stage Award

This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months.

A separate competition combining early and late stages is being run in conjunction with this one. You can apply for the early and late stages without needing to go through feasibility and primer.

For feasibility and primer awards, UK businesses can apply for a share of up to £3 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge. This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months.

The feasibility award is designed for projects that have developed an innovative concept or carried out experimental proof of concept but have not validated the technology. The aim of the feasibility award is to explore and evaluate the commercial potential of innovative ideas. Funding in the primer award is for conducting a technical evaluation of an idea through to proof of concept in a model system.

Your project’s total eligible costs must be between £50,000 and £1 million. Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.

For further information and to apply please click here.